Schaeffer P, Luginer C, Follenius-Wund A, Gerard D, Stoclet J C
Biochem Pharmacol. 1987 Jun 15;36(12):1989-96. doi: 10.1016/0006-2952(87)90498-9.
Experiments were designed to investigate the effect of inhibitors on calmodulin's hydrophobic sites and their consequences on the activation of a target enzyme, cyclic nucleotide phosphodiesterase. Two fluorescent probes, 2-(p-toluidinyl)-naphthalene-6-sulfonate (TNS) and 9-anthroylcholine (9AC) were used to study the interactions with calmodulin of inhibitors devoid of direct effect on the probes. Contrary to W-7, nicergoline, nicardipine and quercetin, which decreased the fluorescence of the two probes bound to calmodulin, bepridil only decreased 9AC fluorescence but increased the fluorescence intensity at the wavelength of the emission maximum of TNS. In spite of this difference, bepridil as well as W-7 and nicergoline competitively inhibited calmodulin activation of phosphodiesterase. In addition, nicergoline also inhibited phosphodiesterase activity competitively to cyclic GMP. These results show differences in the interactions of inhibitors with calmodulin; these differences are not detected in functional studies of the effect of inhibitors on phosphodiesterase activation.
实验旨在研究抑制剂对钙调蛋白疏水位点的影响及其对靶酶环核苷酸磷酸二酯酶激活的后果。使用两种荧光探针,即2-(对甲苯胺基)-萘-6-磺酸盐(TNS)和9-蒽甲胆碱(9AC)来研究与钙调蛋白相互作用的对探针无直接影响的抑制剂。与W-7、尼麦角林、尼卡地平及槲皮素不同,它们会降低与钙调蛋白结合的两种探针的荧光,而苄普地尔仅降低9AC荧光,但增加了TNS发射最大值波长处的荧光强度。尽管存在这种差异,苄普地尔以及W-7和尼麦角林均竞争性抑制磷酸二酯酶的钙调蛋白激活。此外,尼麦角林还对环鸟苷酸竞争性抑制磷酸二酯酶活性。这些结果表明抑制剂与钙调蛋白相互作用存在差异;在抑制剂对磷酸二酯酶激活作用的功能研究中未检测到这些差异。